/
HITC
$0.29+$0.00 (+0.03%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Price (6 mo)
Loading chart…
Change+$0.20
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $322.0K | $0 |
| Cost of revenue | $3.1K | $7.3K | $4.8K | $8.6K | $11.2K | $16.9K | $239.9K | $0 |
| Gross profit | −$3.1K | −$7.3K | −$4.8K | −$8.6K | −$11.2K | −$16.9K | $82.1K | $0 |
| Gross margin | — | — | — | — | — | — | 25.5% | — |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $40.8K | $0 |
| Operating income | −$2.0M | −$784.0K | −$1.0M | −$1.3M | −$1.1M | −$961.6K | −$983.6K | $0 |
| EBITDA | −$1.9M | −$776.7K | −$1.0M | −$1.3M | −$1.1M | −$944.7K | −$425.5K | −$4.2M |
| Net income | −$2.1M | −$877.4K | −$1.1M | −$1.7M | −$1.8M | −$1.3M | −$702.5K | −$4.6M |
| Net margin | — | — | — | — | — | — | -218.2% | — |
| EPS (diluted) | -0.07 | -0.03 | -0.03 | -0.04 | -0.04 | -0.03 | -0.01 | -0.04 |
Annual figures · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.13
Price
$0.29
Implied downside
-57%
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| BSTGBiostage, Inc. | $4.03 | +0.75% | $58M | — |
| HRPMFHerantis Pharma Oyj | $3.51 | +0.00% | $59M | — |
| INNPFINNOCAN PHARMA Corp | $1.70 | -10.53% | $8M | — |
| MCIOFMCI Onehealth Technologies Inc. | $0.55 | -1.10% | $54M | — |
Source: Financial Modeling Prep · peers by sector/industry
Held by traders on TradeandTell
No one on the platform currently holds HITC.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in HITC as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded HITC yet.